Tenon Medical Q3 2026 revenue up 22% to $1.4M; convertible notes repaid after $15.6M raised

Tenon Medical, maker of the SImmetry+ and Catamaran SI joint fusion systems, reported Q3 2026 results on November 12, 2026: revenue of $1.4M, gross margin of 66.3% and a net loss of $6.6M. During the quarter it raised about $15.6M gross, repaid its senior convertible notes early, regained Nasdaq compliance, and began full commercial launch of a 3D-printed lateral screw for SImmetry+. It also added eight U.S. patents and plans a full market release of the Quickstep Decorticator in Q1 2027.

12 Nov 2026 · Tenon Medical, Inc. TNON · Company news

Company's press release (SEC filing): Tenon Medical, Inc. ↗

Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.

More FinancingAll →

Financing

Tenon Medical Q3 2026 revenue up 22% to $1.4M; convertible notes repaid after $15.6M raised

IM Cannabis reports C$13.9M nine-month net loss as revenue slides to C$9.0M

Femasys Q3 2026: $30M private placement closed; U.S. sales flat, total sales fall 44.5% to $404,597

Mingteng International, an automotive mold maker, prices $2.00/share registered direct offering with pre-funded warrants

Organigram to acquire Aurora Cannabis for about C$561M, backed by BAT private placement and ATB credit facilities

Windward Bio prices Nasdaq IPO of 10.3 million shares at $17, targeting $225 million in gross proceeds

Lichen International prices $3.5M registered direct offering of units with warrants on Nasdaq